electroCore Inc. logo

electroCore Inc.

ECOR | NASDAQ
Chart Builder DCF Calculator
$12.54
+$0.54 (+4.54%)
Sep 22, 2026, 12:56 PM ET · Market open

Company Profile

electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.

Key Executives

Name Position
Michael Fox Chief Operating Officer
Amanda Yanuklis Chief of Staff
Andy Brown Vice President & Corporate Controller
Jennifer A. Hayes Vice President of HR & Employee Success
Joshua S. Lev CFO & Interim President
Mitch Deshon Vice President of Sales & New Market Development
Peter S. Staats Chief Medical Officer
Thomas J. Errico Founder & Independent Chairman

Latest SEC Filings

Date Type Title
Aug 25, 2026 4 Filing
Aug 17, 2026 4 Filing
Aug 13, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 06, 2026 10-Q Quarterly Report
Aug 06, 2026 8-K Current Report
Jul 20, 2026 DEF 14A Filing
Jun 12, 2026 4 Filing
May 29, 2026 4 Filing
May 27, 2026 144 Filing
May 27, 2026 144 Filing
View All SEC Filings
electroCore Inc.
electroCore Inc. logo
Country United States
IPO Date Jun 21, 2018
Industry Medical - Devices
Sector Healthcare
Employees 83
CEO Thomas J. Errico

Contact Details

200 Forge Way Rockaway, New Jersey 07866 United States

Stock Details

Ticker Symbol ECOR
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001560258
CUSIP Number 28531P202
ISIN Number US28531P2020
SIC Code 3845

© 2026 bestshares.com. All rights reserved.